The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
North Central Cancer Treatment Group phase II study of panitumumab (Pmab), chemotherapy, and external beam radiation (Chemo-RT) in patients with locally advanced (LA) pancreatic cancer.
George P. Kim
Research Funding - Amgen
Nathan R. Foster
No relevant relationships to disclose
Michael G. Haddock
No relevant relationships to disclose
John William Bollinger
No relevant relationships to disclose
Shaker R. Dakhil
No relevant relationships to disclose
Robert J. Behrens
No relevant relationships to disclose
Patrick J. Flynn
No relevant relationships to disclose
Preston D. Steen
No relevant relationships to disclose
Martin Joseph Bury
No relevant relationships to disclose
Philip J. Stella
No relevant relationships to disclose
Steven R. Alberts
No relevant relationships to disclose